Cite

HARVARD Citation

    Leichman, L. et al. (2016). Phase II Study of Olaparib (AZD‐2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer. Oncologist. pp. 172-177. [Online]. 
  
Back to record